o9 Solutions to supply AI-powered IBP platform to Samsung Bioepis Kumar Jeetendra | February 1, 2021 India, 1st February 2021: o9 Solutions Inc., , a premier AI-powered IBP platform provider, announced that it would supply its next-generation platform to Samsung Bioepis Co., Ltd., bolstering the management of its biopharmaceutical product manufacturing and supply chain. o9 Solutions’ platform will also help Samsung Bioepis optimize its focus on development, clinical trial management, and …
AstraZeneca to supply 9 million more antibody dose to European Union Kumar Jeetendra | February 1, 2021 Pharmaceutical company AstraZeneca has agreed to provide 9 million additional doses of its coronavirus vaccine into the European Union during the first quarter, the bloc’s executive arm said Sunday. The new target of 40 million doses by the end of March is still only half what the British-Swedish firm had originally aimed for before it …
Protein alteration adds to degeneration of neuronal populaces in Huntington’s infection Kumar Jeetendra | February 1, 2021 A study in which UB scientists have taken part states that alterations in the levels of one of those proteins, lamin B1, add to the degeneration of distinct brain neuronal populations in Huntington’s disease. Caused by a mutation in the huntingtin gene, this pathology features involuntary movements, cognitive deficit, and psychiatric disorders, and has no …
Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsody™ Single Cell Analysis system Kumar Jeetendra | February 1, 2021 Virum, Denmark, 1st February 2021 – Life Science Newswire – Immudex ApS has been collaborating with BD (Becton, Dickinson and Company) to create improved solutions for T-cell multi-omics research. The goal of this collaboration was to develop dCODE Dextramer® reagents compatible with the BD Rhapsody™ Single Cell Analysis system, a platform that analyzes the expression …
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021 Kumar Jeetendra | February 1, 2021 The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online. The hybrid event has helped stimulate renewed growth and partnerships across the …
Russia’s Sputnik V antibody 91.6% successful in late-stage preliminary Kumar Jeetendra | February 2, 2021 Russia’s Sputnik V vaccine was 91.6 percent effective in preventing people from growing COVID-19, according to peer-reviewed results from its late-stage clinical trial published in The Lancent global clinical journal on February 2. Scientists said the Phase III trial results meant that the world had another effective weapon to fight the deadly pandemic and justified …
Pfizer sees about $15 billion of every 2021 sales from COVID-19 immunization Kumar Jeetendra | February 2, 2021 Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast. The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion. The vaccine was among the first to be authorized for emergency …
New gold-nanoparticle probes for target recognizable proof of bioactive small molecules Kumar Jeetendra | February 2, 2021 The development of pharmaceutical treatments is difficult — clinicians and researchers know a certain drug can regulate particular functions, but they may not understand how it actually works. Bioactive small molecules are chemical compounds, such as pharmaceuticals, that can be readily delivered to and interact with a human body’s cells. By binding to specific proteins, …
Cipla celebrates 85 years with the launch of its book ‘Caring For Life: The Cipla Story Since 1935’ Kumar Jeetendra | February 2, 2021 Mumbai; February 02, 2021: Cipla Limited referred to as “Cipla” today announced the launch of its book ‘Caring For Life: The Cipla Story Since 1935’. This book traces the evolution of the Indian pharmaceutical company, from its humble beginnings in a rented bungalow in the heart of Bombay to the significant global player that it …
Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult Kumar Jeetendra | February 2, 2021 Nottingham, UK – 2nd February 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with the Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based …
Solid Phase Extraction Microplate Selection Guide Kumar Jeetendra | February 3, 2021 Porvair Sciences announce the availability of a new guide that makes selection of the optimum Solid Phase Extraction (SPE) microplate for your application both quick and easy. SPE is a widely used method of sample preparation that concentrates and purifies analytes from a solution by means of absorption, followed by the elution of the analyte …
Possible antiviral treatment for COVID-19 recognized Kumar Jeetendra | February 3, 2021 Researchers have identified an antiviral drug that’s highly effective against the COVID-19 causing coronavirus, and may have significant implications in how future disease outbreaks are handled. The team, including researchers at the University of Nottingham in the UK, found that the plant-derived antiviral, in small doses, triggers an extremely effective broad-spectrum host-centred antiviral innate immune …
